MNOVMediciNova, Inc.

$69M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$15M

Net Income

-$14M

EPS (Diluted)

$-0.29

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$642,522

Balance Sheet

Total Assets

$74M

Total Liabilities

$4M

Stockholders' Equity

$70M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$4M	-100.0%
Gross Profit	$0	$4M	-100.0%
Operating Income	-$15M	-$10M	-43.2%
Net Income	-$14M	-$10M	-38.8%

MNOV FY 2022 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena